Pfizer ApS - Резултати от търсенето

pfizer australia pty ltd - piroxicam, quantity: 10 mg - capsule, hard - excipient ingredients: lactose monohydrate; sodium lauryl sulfate; maize starch; magnesium stearate - feldene is indicated for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

dantrium dantrolene sodium hemiheptahydrate 50mg capsule bottle

pfizer australia pty ltd - dantrolene sodium hemiheptahydrate, quantity: 50 mg - capsule - excipient ingredients: sodium lauryl sulfate; maize starch; lactose monohydrate; titanium dioxide; sunset yellow fcf; gelatin; iron oxide yellow; iron oxide red; magnesium stearate; purified talc; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - dantrium is indicated in controlling the manifestations of clinical spasticity resulting from serious chronic disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. there is no evidence that patients with contractures will benefit. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders or electroconvulsive therapy. if improvement occurs, it will ordinarily occur within the dosage titration schedule (see dosage and administration), as manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrium. occasionally, subtle but meaningful improvements in spasticity may occur with dantrium therapy. in such instances informat

Австралия - английски - Department of Health (Therapeutic Goods Administration)

dantrium dantrolene sodium hemiheptahydrate 25mg capsule bottle

pfizer australia pty ltd - dantrolene sodium hemiheptahydrate, quantity: 25 mg - capsule - excipient ingredients: titanium dioxide; sunset yellow fcf; purified talc; gelatin; iron oxide red; magnesium stearate; maize starch; sodium lauryl sulfate; lactose monohydrate; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - dantrium is indicated in controlling the manifestations of clinical spasticity resulting from serious chronic disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. there is no evidence that patients with contractures will benefit. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders or electroconvulsive therapy. if improvement occurs, it will ordinarily occur within the dosage titration schedule (see dosage and administration), as manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrium. occasionally, subtle but meaningful improvements in spasticity may occur with dantrium therapy. in such instances inf

Ирландия - английски - HPRA (Health Products Regulatory Authority)

celecoxib pfizer 200 mg capsules, hard

pfizer healthcare ireland - celecoxib; gelatin - capsule, hard - 200 milligram(s) - coxibs; celecoxib